| Dr Marvin A Kirschner, MD | |
|
90 Bergen St, Suite 4500, Newark, NJ 07103-2425 | |
| (973) 972-6171 | |
| (972) 972-5185 |
| Full Name | Dr Marvin A Kirschner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 90 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386784551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 023290 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marvin A Kirschner, MD 185 S Orange Ave, Msb-i-588, Newark, NJ 07103-2757 Ph: (973) 972-6171 | Dr Marvin A Kirschner, MD 90 Bergen St, Suite 4500, Newark, NJ 07103-2425 Ph: (973) 972-6171 |
News Archive
Researchers at the Center for Biomedical Inventions at UT Southwestern Medical Center at Dallas have identified the genetic changes that Mycobacterium tuberculosis, the bacterium that causes tuberculosis, undergoes during infection of a living host.
Americans are being exposed to significantly lower levels of some phthalates that were banned from children's articles in 2008, but exposures to other forms of these chemicals are rising steeply, according to a study led by researchers at UC San Francisco.
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Transmission of COVID-19 from mother to baby during pregnancy is uncommon, and the rate of infection is no greater when the baby is born vaginally, breastfed or allowed contact with the mother, according to a new study.
The Bloomfield, Conn., managed-care company significantly boosted its full-year adjusted earnings guidance after posting better results than Wall Street expected. The company Thursday also announced a restructuring plan that includes reducing the size of its global workforce about 4%, affecting 1,300 workers amid a mix of layoffs and hiring. Cigna continued a streak of "beat and raise" third-quarter reports for large health insurers.
› Verified 9 days ago
Dr. Xiaoning Joanie Zhu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |